Bernard Bonnotte

Rituximab versus Azathioprine for Maintenance in ANCA-Associated Vasculitis

Christian Pagnoux, Alexandre Karras, C. Khouatra et al. · New England Journal of Medicine · 2014 · 1.1K citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

CD4⁺CD25⁺ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative

François Ghiringhelli, Nicolas Larmonier, E. Schmitt et al. · European Journal of Immunology · 2004 · 868 citations

Life Sciences, Immunology, Oncology +17

Doxorubicin Eliminates Myeloid-Derived Suppressor Cells and Enhances the Efficacy of Adoptive T-Cell Transfer in Breast Cancer

Darya Alizadeh, Malika Trad, Neale T. Hanke et al. · Cancer Research · 2013 · 409 citations · Full text

Medicine, Immunology, Oncology +17

Brief Report: Inhibition of interleukin‐6 function corrects Th17/Treg cell imbalance in patients with rheumatoid arthritis

M. Samson, Sylvain Audia, Nona Janikashvili et al. · Arthritis & Rheumatism · 2012 · 345 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2)

Pierre Charles, Benjamin Terrier, Élodie Perrodeau et al. · Annals of the Rheumatic Diseases · 2018 · 336 citations

Life Sciences, Immunology, Pharmacotherapy +15